Source: 4-traders

Cynapsus: Sumitomo Chemical : Sunovion Pharmaceuticals Completes Acquisition of Cynapsus Therapeutics

(4-traders.com) Sunovion Pharmaceuticals Inc. (Sunovion) and Cynapsus Therapeutics Inc. (Cynapsus) today announced that Sunovion has completed, through its wholly owned subsidiary, Sunovion CNS Development Canada ULC (the Purchaser), the previously announced acquisition of Cynapsus (the Acquisition). The Acquisition is aligned with Sunovions global strategy to...http://www.4-traders.com/SUMITOMO-CHEMICAL-CO-LTD-6491327/news/Sumitomo-Chemical-Sunovion-Pharmaceuticals-Completes-Acquisition-of-Cynapsus-Therapeutics-23256968/

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Anthony J. Giovinazzo's photo - President & CEO of Cynapsus

President & CEO

Anthony J. Giovinazzo

CEO Approval Rating

68/100

Read more